Search Result "anti-PCSK9 antibody"
Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1484-1494
Author(s): Joel Schmitz,Ioanna Gouni-Berthold
Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin Intolerance
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 13 Year: 2018 Page: 1538-1548
Author(s): Julia Schreml,Ioanna Gouni-Berthold
Analysis of Adherence to anti-PCSK9 Antibody Therapy among Patients from Italy
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 111-121
Author(s):
The Immunogenic Potential of PCSK9 Peptide Vaccine in Mice
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 26 Year: 2023 Page: 3024-3031
Author(s): Amir Abbas Momtazi-Borojeni
PCSK9 Inhibition-Based Therapeutic Approaches: An ImmunotherapyPerspective
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 980-999
Author(s): Amirhossein Sahebkar,Suowen Xu,Matteo Pirro,Amir Abbas Momtazi-Borojeni
Monoclonal Antibodies: A Prospective and Retrospective View
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 3 Year: 2021 Page: 435-471
Author(s): Jwala Sivaccumar,Annamaria Sandomenico,Luigi Vitagliano,Menotti Ruvo
PCSK9 as a New Player in Cancer: New Opportunity or Red Herring?
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 960-969
Author(s): Francesco Dentali,Francesco Grossi,Massimiliano Ruscica,Alessandra Vecchié,Aldo Bonaventura
SKY59, A Novel Recycling Antibody for Complement-mediated Diseases
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 25 Year: 2020 Page: 4157-4164
Author(s): Taku Fukuzawa,Junichi Nezu
Transgenic Mouse Strains as Platforms for the Successful Discovery and Development of Human Therapeutic Monoclonal Antibodies
Journal: Current Drug Discovery Technologies
Volume: 11 Issue: 1 Year: 2014 Page: 74-84
Author(s): Larry L. Green
Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3638-3646
Author(s): Vasilios G. Athyros,Niki Katsiki,Aikaterini Dimakopoulou,Dimitrios Patoulias,Sofia Alataki,Michael Doumas